Basic Information
ConfometRx is developing a structure-based drug discovery platform to facilitate target validation, lead identification, and optimization for G protein-coupled receptor (GPCR) targets. ConfometRx is currently advancing several small molecule candidates through lead optimization and preclinical development targeting GPCR targets for central nervous system, respiratory, metabolic, and other diseases.
ConfometRx, Inc.
California,United States of America
unclear
January 01, 2005
--
Enterprise Profile
Industrial Sector
Concept
Application Scenarios